Myriam Chalabi
Onco
Daily
Twitter
Facebook
Youtube
RSS Feed
Linkedin
Facebook
RSS
Twitter
Youtube
Linkedin
July, 2024
July 2024
M
T
W
T
F
S
S
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
25
26
27
28
29
30
31
« Jun
Myriam Chalabi
Jul 21, 2024, 04:10 |
OncoDaily Pulse
OncoDaily Party and Yvonne Award Photos - Part 1
On May 31st, 2024, during the ASCO Annual Meeting in Chicago, OncoDaily hosted the inaugural…
Jul 11, 2024, 17:37 |
Blog
Myriam Chalabi: An important international study on whether high TILs can be used to safely omit chemotherapy in TNBC
Myriam Chalabi shared a post by The Netherlands Cancer Institute, on X, adding: ''Congratulation Marleen Kok…
Jul 10, 2024, 11:57 |
Blog
The 2024 Uromigos Cup
Uromigos formed in early 2017 as a group of friends attempting to provide balanced, scientific content…
Jul 2, 2024, 07:19 |
Societies
25 Posts You Should Not Miss From ESMOGI24!
ESMOGI24 took place as an onsite event in Munich, Germany, from 26 to 29 June…
Jul 2, 2024, 03:02 |
Blog
Myriam Chalabi: Patients with stage 1c TNBC with high TILs have an excellent prognosis without chemo
Myriam Chalabi, Medical Oncologist and Cancer Immunotherapy researcher at Antoni van Leeuwenhoek, shared a post…
Jun 30, 2024, 14:51 |
Insight
Sergio Cifuentes: Phase 2 study on neoadjuvant nivolumab + ipilimumab in dMMR colon cancer
Sergio Cifuentes, Cancer Research Project Manager at CENEIT México, shared a post on X about…
Jun 30, 2024, 08:07 |
Societies
9 Posts You Should Not Miss From Day 3 of ESMOGI24!
ESMOGI24 is taking place as an onsite event in Munich, Germany, from 26 to 29 June 2024,…
Jun 28, 2024, 13:42 |
Societies
NEST Trial highlighted by Myriam Chalabi
Pashtoon Kasi shared on LinkedIn: "NEST Trial highlighted by Myriam Chalabi. Link to the ESMO…
Jun 28, 2024, 11:28 |
Societies
Keynote address by Myriam Chalabi at ESMOGI24
Toni Choueiri shared on X: "Keynote address at ESMOGI24 with superstar Myriam Chalabi- Immunotherapy for…
Jun 28, 2024, 11:27 |
Societies
12 Posts You Should Not Miss From Day 2 of ESMOGI24!
ESMOGI24 is taking place as an onsite event in Munich, Germany, from 26 to 29 June 2024,…
Jun 28, 2024, 10:52 |
Societies
Learn more about overcoming barriers to immunotherapy for microsatellite stable colorectal cancer
ESMO shared a post on LinkedIn: "ESMOGI24: Colorectal Cancer (CRC) can be classified into two…
Jun 28, 2024, 09:48 |
Societies
Mark Lewis: Thank you for what you are doing for our field, Myriam Chalabi
Mark Lewis shared on X: "Ok, I’ll admit I’m star-struck. Not every day you meet…
Jun 27, 2024, 10:23 |
Insight
ESMO announces the the ESMO GI Ambassadors
The European Society for Medical Oncology (ESMO) shared on LinkedIn: “ESMOGI24: ESMO is excited to…
Jun 19, 2024, 09:11 |
Societies
Kai-Keen Shiu: Love all the data on neoadjuvant IO at ASCO24!
Kai-Keen Shiu, a Medical Oncology Consultant for the Gastrointestinal Oncology Service at University College London…
Jun 12, 2024, 17:27 |
Blog
Winette van der Graaf: Two papers in the New England Journal of Medicine in one week
Winette van der Graaf shared a post on their LinkedIn: ''Extremely proud and grateful for…
Jun 10, 2024, 06:14 |
Blog
Myriam Chalabi: Happy moment with Christian Blank
Myriam Chalabi, Medical Oncologist and Cancer Immunotherapy researcher at Antoni van Leeuwenhoek, shared a post…
Jun 10, 2024, 03:19 |
Blog
Myriam Chalabi: What a week it has been for neoadjuvant immunotherapy
Myriam Chalabi, Medical Oncologist and Cancer Immunotherapy researcher at Netherlands Cancer Institute, shared a post…
Jun 8, 2024, 06:59 |
Blog
Results of the NICHE-2 trial show it to be highly effective in a subset of patients with colon cancer - The Netherlands Cancer Institute
The Netherlands Cancer Institute shared on Linkedin: “More succes for neoadjuvant immunotherapy: results of the…
Jun 8, 2024, 02:16 |
Blog
Toni Choueiri: NICHE-2 by Myriam Chalabi published in NEJM
Toni Choueiri shared a post on X: , "NICHE-2 published…
Jun 7, 2024, 14:08 |
Blog
Mark Lewis: Myriam Chalabi reporting the NICHE-2 trial in NEJM
Mark Lewis shared on X: . "TLC: don't…
Jun 7, 2024, 09:11 |
Insight
Results of the NICHE-2 study by Myriam Chalabi - The Netherlands Cancer Institute
The Netherlands Cancer Institute (NKI) shared on X: "More success for neoadjuvant immunotherapy: results of…
Jun 7, 2024, 08:23 |
Blog
Myriam Chalabi: The results of the NICHE-2 study now published in NEJM
Myriam Chalabi, Medical Oncologist and Cancer Immunotherapy researcher at Antoni van Leeuwenhoek, shared a post…
Jun 7, 2024, 03:12 |
Blog
Pashtoon Kasi: Chalabi Plot now in print
Pashtoon Kasi shared a post on X: "Chalabi Plot now in print. Congratulations Myriam Chalabi/article/ With an…
Jun 7, 2024, 01:18 |
Insight
Giuseppe Curigliano: Congratulations to Myriam Chalabi on her outstanding paper
Giuseppe Curigliano shared a post by NEJM on X: "Congratulations to Myriam Chalabi on her outstanding…
May 25, 2024, 01:55 |
Blog
Myriam Chalabi: ESMO voting starts May 28th
Myriam Chalabi shared a post by ESMO on X/Twitter: "For those not eager on clicking to…
May 4, 2024, 07:02 |
Blog
Myriam Chalabi: Looking forward to reading all the exciting lower GI abstracts!
Myriam Chalabi shared a post by ESMO on X, adding: "May 7th. ESMO24 deadline! Looking…
Apr 26, 2024, 11:57 |
Blog
Myriam Chalabi: What happens in Zurich….goes to ESMO25
Myriam Chalabi shared on X/Twitter: ''What happens in Zurich….goes to ESMO25! Fantastic meeting and discussions…
Apr 26, 2024, 11:10 |
Blog
Vivek Subbiah: The world of oncology converges in Zurich, Switzerland!
Vivek Subbiah posted on X/Twitter: ''The world of oncology converges in Zurich, Switzerland! Such an…
Apr 25, 2024, 12:10 |
Blog
Myriam Chalabi: Very happy to host Ulrike Harjes from Nature Medicine
Myriam Chalabi: Medical Oncologist and Cancer Immunotherapy Researcher at Antoni van Leeuwenhoek, The Netherlands Cancer…
Apr 24, 2024, 12:07 |
Blog
Vivek Subbiah: One mission = Eradicate cancer
Vivek Subbiah shared on Twitter/X: "One of the greatest advantages of in person scientific meetings is…
Mar 5, 2024, 14:22 |
Blog
GI Oncology voices that stand out - as selected by peer survey - LARVOL
Quoting LARVOL on LinkedIn: "Diving into the discussions on X (formerly Twitter) around GI Oncology,…
Feb 12, 2024, 01:51 |
Blog
Myriam Chalabi: Very grateful for the people who can appreciate assertiveness in women!
Myriam Chalabi, Medical Oncologist and Cancer Immunotherapy researcher at Antoni van Leeuwenhoek, The Netherlands Cancer…
Jan 29, 2024, 03:56 |
Insight
Myriam Chalabi: The Phase 2 PANDA Trial is out in Nature Medicine
Myriam Chalabi, Medical Oncologist and Cancer Immunotherapy researcher at Antoni van Leeuwenhoek, The Netherlands Cancer…
Jan 27, 2024, 08:09 |
Blog
Myriam Chalabi: First results of the CM8HW are out!
Myriam Chalabi shared a post on X/Twitter: "First results of the CM8HW are out! Nivo/ipi…
Jan 26, 2024, 17:17 |
Societies
30 Posts Not To Miss From ASCO GI24
The ASCO Gastrointestinal Cancer Symposium (GI24) took place from the 18th to the 20th of…
Oct 24, 2023, 16:09 |
Societies
ESMO congratulates the recipients of the 2023 Research Fellowships and the José Baselga Fellowship
ESMO posted on their Twitter page: "ESMO congratulates the recipients of the 2023 Research Fellowships…
Oct 22, 2023, 14:22 |
Blog
Myriam Chalabi: Honored to receive the Jose Baselga fellowship
Myriam Chalabi posted on her Twitter page: "Day 3 of ESMO23: early start heading to the…
Aug 26, 2023, 17:08 |
Positive
100 Influential Women in Oncology: Key Opinion Leaders to follow on Social Media in 2023
Today is Women's Equality Day, celebrating the 1920 law that granted U.S. women the right…
Jul 20, 2023, 16:44 |
Blog
I was amazed how much I had to change - Kathrin Heinrich
While updating the presentation (~ 5 years old) for a student's lecture on colorectal cancer…
All:
39
Posts:
1 - 100
The largest philanthropic partnership in The V Foundation’s history - Dolphins Cancer Challenge
Glecirasib: A Promising Novel KRAS G12C Inhibitor in Clinical Development
How the Médecins Sans Frontières Journal Inspired a Lifetime of Humanitarian Service: Paul Spiegel
OncoDaily Party and Yvonne Award Photos - Part 1
Michael Douglas: The Untold Story of His Battle Against Cancer
Facebook
RSS Feed
Twitter
Linkedin
Youtube